Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy.
Quick navigation
Link to full study
http://www.ncbi.nlm.nih.gov/pubmed/21443422
Conclusion of this study
This study shows that ALC treatment is associated with significant improvement in patient energy levels, general functioning and well-being. The improvement of quality of life is associated with reduction of anxiety and depression.
Supplements analyzed in this study
Health conditions analyzed in this study
Functions related to this study
Body systems related to this study
